Medicare does not typically cover ketamine infusions for mental health conditions. However, it may cover Spravato, an FDA-approved drug deriving from ketamine, for treatment-resistant depression.

Between November 2023 and October 2024, these selected drugs accounted for about $41 billion in total covered prescription drug costs under Medicare Part D, or about 14%, according to the U.S ...

Together, those 25 drugs account for a third of Medicare spending on prescriptions, Becerra said. Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs.

The ACA affects nearly every aspect of the U.S. healthcare system, including: Previously, when a person with Medicare Part D coverage reached a certain amount of out-of-pocket costs, they would ...

After 100 days, Medicare will no longer provide coverage. Another cost that Medicare does not cover is custodial care. If someone’s wounds make it difficult for them to perform activities such ...

He linked his complaint to proposed legislation to make weight-loss drugs like Ozempic and Wegovy ... This means expanded coverage to Medicare is projected to cost the government around $35 ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

“More than 34 million seniors and people with disabilities choose Medicare Advantage for their health coverage ... out-of-pocket costs, something traditional Medicare does not do.